GCM2
Chorion-specific transcription factor GCMb
Also known as: GCM2_HUMAN, GCMB, hGCMb
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75603
- Gene
- GCM2
- Ensembl
- ENSG00000124827
- Chromosome
- 6
- Canonical length
- 506 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
OverviewNCBI Gene
This gene is a homolog of the Drosophila glial cells missing gene, which is thought to act as a binary switch between neuronal and glial cell determination. The protein encoded by this gene contains a conserved N-terminal GCM motif that has DNA-binding activity. The protein is a transcription factor that acts as a master regulator of parathyroid development. It has been suggested that this transcription factor might mediate the effect of calcium on parathyroid hormone expression and secretion in parathyroid cells. Mutations in this gene are associated with hypoparathyroidism. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
506 residues, UniProt reviewed canonical sequence.
>O75603|GCM2
1 MPAAAVQEAV GVCSYGMQLS WDINDPQMPQ ELALFDQFRE WPDGYVRFIY SSDEKKAQRH
61 LSGWAMRNTN NHNGHILKKS CLGVVVCTQA CTLPDGSRLQ LRPAICDKAR LKQQKKACPN
121 CHSALELIPC RGHSGYPVTN FWRLDGNAIF FQAKGVHDHP RPESKSETEA RRSAIKRQMA
181 SFYQPQKKRI RESEAEENQD SSGHFSNIPP LENPEDFDIV TETSFPIPGQ PCPSFPKSDV
241 YKATCDLATF QGDKMPPFQK YSSPRIYLPR PPCSYELANP GYTNSSPYPT LYKDSTSIPN
301 DTDWVHLNTL QCNVNSYSSY ERSFDFTNKQ HGWKPALGKP SLVERTNHGQ FQAMATRPYY
361 NPELPCRYLT TPPPGAPALQ TVITTTTKVS YQAYQPPAMK YSDSVREVKS LSSCNYAPED
421 TGMSVYPEPW GPPVTVTRAA SPSGPPPMKI AGDCRAIRPT VAIPHEPVSS RTDEAETWDV
481 CLSGLGSAVS YSDRVGPFFT YNNEDFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GCM2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.59
- Highest tissue expression
- 247 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 247 nTPM
- testis: 0.4 nTPM
- epididymis: 0.3 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
- amygdala: 0 nTPM
Single-cell type
- epicardial cells: 4.5 nCPM
- retinal amacrine cells: 3.2 nCPM
- late primary spermatocytes: 2.7 nCPM
- cone photoreceptor cells: 2.1 nCPM
- fibro-adipogenic progenitors: 1.3 nCPM
- early spermatids: 0.9 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 3.2 nTPM
- cerebral cortex: 2.9 nTPM
- amygdala: 2.4 nTPM
- basal ganglia: 2.4 nTPM
- white matter: 2.3 nTPM
- hippocampal formation: 1.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GCM2.
Disease | AllUniProt
Conditions GCM2 is implicated in, by any mechanism.
- Hypoparathyroidism, familial isolated, 2 (FIH2) MIM:618883
- Hyperparathyroidism 4 (HRPT4) MIM:617343
Disease | GeneticClinVar
22 pathogenic / likely-pathogenic of 297 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hypoparathyroidism, familial isolated, 2
- Hyperparathyroidism 4
- Familial hypoparathyroidism
- GCM2-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.8
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.68
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- gliogenesis
- intracellular calcium ion homeostasis
- intracellular phosphate ion homeostasis
- parathyroid gland development
- regulation of transcription by RNA polymerase II
- transcription by RNA polymerase II
Molecular functions
- DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- metal ion binding
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GCM2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GCM2 as an antibody target. Whether an autoantibody or antibody against GCM2 could matter depends on whether native GCM2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GCM2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GCM2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...